Epidemiology of Community Origin
E. coli
K. pneumoniae
antibiotic resistance
urinary tract infection
Journal
Infection and drug resistance
ISSN: 1178-6973
Titre abrégé: Infect Drug Resist
Pays: New Zealand
ID NLM: 101550216
Informations de publication
Date de publication:
2021
2021
Historique:
received:
08
12
2020
accepted:
06
01
2021
entrez:
24
2
2021
pubmed:
25
2
2021
medline:
25
2
2021
Statut:
epublish
Résumé
Urinary tract infection is one of the major causes of consultation, microbiologic exploration, intensive use of antibiotics worldwide, and the second leading cause of clinical consultation in community practice. Many bacteria play a role in the urinary tract infections etiology, including The study's main objective was to examine the epidemiology of The study was carried out between January 2018 and June 2019 in Franceville South-East Gabon. We examined a total of 1086 cytobacteriological urine samples. The identification of The prevalence of urinary tract infections was 29.2% (317/1086), of which 25.1% and 4.1% were mono-infections and co-infections, respectively. The prevalence of UTIs with This study showed a high prevalence of urinary tract infections with a major implication of
Identifiants
pubmed: 33623399
doi: 10.2147/IDR.S296054
pii: 296054
pmc: PMC7896796
doi:
Types de publication
Journal Article
Langues
eng
Pagination
585-594Informations de copyright
© 2021 Mouanga Ndzime et al.
Déclaration de conflit d'intérêts
The authors declare that they have no conflicts of interest for this work.
Références
J Antimicrob Chemother. 2007 Feb;59(2):309-12
pubmed: 17138569
Int J Microbiol. 2016;2016:3240268
pubmed: 27667998
Am J Trop Med Hyg. 2000 Nov-Dec;63(5-6):259-63
pubmed: 11421374
J Antimicrob Chemother. 2014 Sep;69(9):2337-53
pubmed: 24879668
Pediatr Clin North Am. 2006 Jun;53(3):379-400, vi
pubmed: 16716786
Med Sci Monit. 2007 Jun;13(6):BR136-44
pubmed: 17534228
Cent European J Urol. 2019;72(2):209-214
pubmed: 31482032
BMC Infect Dis. 2013 Jan 18;13:19
pubmed: 23327474
Int J Antimicrob Agents. 2017 Nov;50(5):629-639
pubmed: 28705671
J Infect Dev Ctries. 2007 Dec 01;1(3):263-8
pubmed: 19734603
J Antimicrob Chemother. 2003 Jan;51(1):192-4
pubmed: 12493816
BMC Infect Dis. 2017 Sep 11;17(1):616
pubmed: 28893183
Clin Microbiol Infect. 2012 Mar;18(3):268-81
pubmed: 21793988
Adv Exp Med Biol. 2020 Jun 29;:
pubmed: 32596751
Int J Antimicrob Agents. 2002 Nov;20(5):339-47
pubmed: 12431869
J Antimicrob Chemother. 2013 Sep;68(9):2140-3
pubmed: 23645586
Burns. 2003 Mar;29(2):129-32
pubmed: 12615458
Health Technol Assess. 2016 Jul;20(51):1-294
pubmed: 27401902
Infect Drug Resist. 2020 Jun 17;13:1839-1850
pubmed: 32606833
J Antimicrob Chemother. 2007 Jan;59(1):152-6
pubmed: 17124192
Soc Sci Med. 2003 Aug;57(4):733-44
pubmed: 12821020
World J Urol. 1999 Dec;17(6):372-82
pubmed: 10654368
J Am Board Fam Med. 2007 Nov-Dec;20(6):533-9
pubmed: 17954860
Antibiotics (Basel). 2019 Aug 27;8(3):
pubmed: 31461842
Am J Trop Med Hyg. 2011 Jun;84(6):923-8
pubmed: 21633029
Prog Urol. 2014 Dec;24(16):1058-62
pubmed: 25310915
Antibiotics (Basel). 2019 Sep 09;8(3):
pubmed: 31505817
Life (Basel). 2020 Feb 11;10(2):
pubmed: 32054054